Scholarly Index
James D. Griffin
Dana-Farber Cancer Institute; 44,921 total citations; 465 total publications; best world rank #23
Dana-Farber Cancer Institute
44,921Total citations
465Total publications
110H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Chronic Myeloid Leukemia Treatments | Lifetime | 23 | US 19 | 99.81 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 64 | US 40 | 99.73 |
| Acute Myeloid Leukemia Research | Lifetime | 123 | US 68 | 99.59 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 154 | US 77 | 98.94 |
| Eosinophilic Disorders and Syndromes | Lifetime | 156 | US 80 | 98.64 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 818 | US 425 | 98.70 |
| Quinazolinone synthesis and applications | Lifetime | 112 | US 19 | 96.90 |
| Immune cells in cancer | Lifetime | 373 | US 150 | 97.88 |
| Acute Lymphoblastic Leukemia research | Lifetime | 455 | US 228 | 98.27 |
| Cell Adhesion Molecules Research | Lifetime | 757 | US 369 | 97.83 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 422 | US 187 | 97.00 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 530 | US 291 | 96.11 |
| Retinoids in leukemia and cellular processes | Lifetime | 857 | US 411 | 94.06 |